Table 3 Impact of patients’ characteristics and comorbidities on adherence and persistence to UC treatments
Adherence | Persistence | |||
|---|---|---|---|---|
Patient’s adherent over 12 months n (%) | Adjusted OR [95% CI] | Patient’s persistent at 12 months n (%) | Adjusted OR [95% CI] | |
Sex | ||||
· Male | 222 (30.5) | 1.3 | 365 (50.1) | 1.4 |
· Female | 243 (25.5) | [1.05–1.6] | 400 (42.0) | [1.1–1.7] |
Age | ||||
· < 60 | 201 (23.3) | 1.6 | 381 (44.1) | NS |
· ≥ 60 | 264 (32.3) | [1.3–2.0] | 384 (49.9) | |
Previous use of corticosteroids | ||||
· Yes | 142 (28.2) | NS | 231 (45.8) | NS |
· No | 323 (27.4) | 534 (45.4) | ||
Concurrent use of corticosteroids | ||||
· Yes | 179 (32.7) | 1.4 | 273 (49.8) | 1.4 |
· No | 286 (25.2) | [1.1–1.8] | 492 (43.4) | [1.1–1.7] |
Heart disease | ||||
· Yes | 210 (30.2) | NS | 321 (46.2) | NS |
· No | 255 (25.9) | 444 (45.0) | ||
Respiratory illness | ||||
· Yes | 153 (26.8) | NS | 247 (43.3) | 1.2 |
· No | 312 (28.1) | 518 (46.6) | [1.004–1.548] | |
Hypertension | ||||
· Yes | 262 (31.1) | NS | 403 (47.9) | 1.2 |
· No | 203 (24.2) | 362 (43.1) | [1.01–1.50] | |
Diabetes | ||||
· Yes | 167 (30.4) | NS | 515 (45.5) | NS |
· No | 298 (26.3) | 250 (45.5) | ||
Chronic disease score | ||||
· Yes | 159 (23.2) | NS | 296 (43.3) | NS |
· No | 306 (30.7) | 469 (47.0) | ||